Table 8 Comparative analysis of the experimental performance on the best F-measure six gene datasets.
From: Discriminative biomarker selection using hybrid multi-population evolutionary computation
Data | Kfold | Proposed | GA | PSO | DE | TLBO | GSA | Data | Proposed | GA | PSO | DE | TLBO | GSA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lung | 2 | 98.52 | 94.25 | 93.48 | 96.02 | 91.26 | 90.32 | SRBCT | 99.65 | 95.63 | 92.66 | 94.78 | 91.33 | 96.38 |
4 | 100 | 96.22 | 90.25 | 91.99 | 93.78 | 91.63 | 98.62 | 95.84 | 93.88 | 91.02 | 90.02 | 93.78 | ||
6 | 97.66 | 89.32 | 93.78 | 90.48 | 93.65 | 89.3 | 100 | 97.25 | 96.71 | 93.65 | 93.78 | 96.78 | ||
8 | 95.63 | 90.64 | 90.55 | 92.78 | 100 | 88.12 | 99.03 | 98.36 | 90.01 | 95.78 | 91.85 | 95.63 | ||
10 | 90.88 | 91.36 | 91.65 | 91.66 | 88.25 | 88.88 | 97.52 | 92.65 | 93.66 | 96.55 | 93.88 | 97.12 | ||
MLL | 2 | 88.25 | 87.36 | 79.36 | 84.32 | 76.95 | 77.41 | CNS | 88.25 | 84.63 | 86.36 | 77.52 | 76.35 | 81.35 |
4 | 90.78 | 80.02 | 78.21 | 77.94 | 77.25 | 72.36 | 80.02 | 80.01 | 87.54 | 78.63 | 79.62 | 82.65 | ||
6 | 89.34 | 83.55 | 77.65 | 71.65 | 78.38 | 78.62 | 88.14 | 81.36 | 86.55 | 78.95 | 77.85 | 80.05 | ||
8 | 91.87 | 81.63 | 72.96 | 75.38 | 70.14 | 77.62 | 81.11 | 82.63 | 85.96 | 71.02 | 79.65 | 80 | ||
10 | 92.45 | 80.32 | 79.03 | 75.33 | 74.63 | 71.02 | 82.94 | 86.55 | 83.78 | 70.09 | 80.54 | 79.99 | ||
Leukemia | 2 | 80.26 | 77.61 | 82.12 | 80.32 | 80.32 | 71.6 | Ovarian | 84.65 | 80.03 | 79.54 | 79.63 | 80.24 | 88.95 |
4 | 81.63 | 76.95 | 81.96 | 79.03 | 81.33 | 74.63 | 88.06 | 80.07 | 77.25 | 80.05 | 81.99 | 80.41 | ||
6 | 82.78 | 74.02 | 88.45 | 82.33 | 78.14 | 75.95 | 87.09 | 81.65 | 79.6 | 78.14 | 82.47 | 78.58 | ||
8 | 81.66 | 70.22 | 81.97 | 78.41 | 77.96 | 78.55 | 88.95 | 83.74 | 78.18 | 77.11 | 81.63 | 77.94 | ||
10 | 78.22 | 74.3 | 79.99 | 79.86 | 73.85 | 73.45 | 87.65 | 83.74 | 77.98 | 79.65 | 85.27 | 72.85 |